Reuters: U.S. FDA to ask panel about anemia drug limits

[NaDiNe]

U.S. FDA to ask panel about anemia drug limits
      

WASHINGTON (Reuters) - U.S. health officials will ask an advisory panel whether they should withdraw the approval of Amgen Inc and Johnson & Johnson anemia drugs for cancer chemotherapy patients or take other steps to minimize risks, documents released on Tuesday said.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login